Company Profiles

driven by the PitchBook Platform

Peloton Therapeutics

Description

Developer of early-stage cancer drugs. The company is an oncology drug discovery and development firm focused on advancing new small-molecule therapies for life-threatening diseases.

2011

Founded

PRIVATE

Status

11-50

Employees

Series D

Latest Deal Type

$52.4M

Latest Deal Amount

$98.7M

Total Amount Raised

Description

Developer of early-stage cancer drugs. The company is an oncology drug discovery and development firm focused on advancing new small-molecule therapies for life-threatening diseases.

Website:

www.pelotontherapeutics.com

Formerly Known As

Damascus Pharmaceuticals

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Drug Delivery
Biotechnology

Primary Office

2330 Inwood Road Suite 226 Dallas, TX 75235United States +1 (972) 629-4100
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Peloton Therapeutics's full profile, request a free trial.

Peloton Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Peloton Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Peloton Therapeutics Investors (9)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Cancer Prevention and Research Institute of TexasGovernment000 0000000 0000
Foresite Capital ManagementVenture CapitalMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
National Cancer InstituteGovernment000 0000000 0000
Nextech InvestVenture CapitalMinority000 0000000 0000
Cancer Prevention and Research Institute of Texas Government
Foresite Capital Management Venture Capital
Individual Investor Angel (individual)
National Cancer Institute Government
Nextech Invest Venture Capital

Peloton Therapeutics Executive Team (11)

NameTitleBoard
Seat
Contact
Info
John Josey Ph.DChief Executive Officer & Board Member
Eli Wallace Ph.DChief Scientific Officer
Zhaodan Cao Ph.DDirector, Biology
Peter Stengel Ph.DDirector, Chemical Development
Michael Haller Ph.DChief Business Officer
John Josey Ph.D Chief Executive Officer & Board Member
Eli Wallace Ph.D Chief Scientific Officer
Zhaodan Cao Ph.D Director, Biology
Peter Stengel Ph.D Director, Chemical Development
Michael Haller Ph.D Chief Business Officer

Peloton Therapeutics Board Members (9)

NameRepresentingRoleSinceContact
Info
Brett RingleRemeditex VenturesPresident & Director000 0000
David Goeddel Ph.DThe Column GroupManaging Partner000 0000
Frank McCormick Ph.DSelfBoard Member000 0000
John CreecyRemeditex VenturesChief Executive Officer & Director000 0000
John Josey Ph.DPeloton TherapeuticsChief Executive Officer & Board Member000 0000
Brett Ringle President & Director Remeditex Ventures
David Goeddel Ph.D Managing Partner The Column Group
Frank McCormick Ph.D Board Member Self
John Creecy Chief Executive Officer & Director Remeditex Ventures
John Josey Ph.D Chief Executive Officer & Board Member Peloton Therapeutics
Request full access to PitchBook